Neus Rabaneda-Lombarte, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microglia | 3 | 2022 | 1335 | 0.910 |
Why?
|
| Neuroleptic Malignant Syndrome | 1 | 2023 | 73 | 0.860 |
Why?
|
| Pain, Intractable | 1 | 2023 | 131 | 0.820 |
Why?
|
| Hydronephrosis | 1 | 2023 | 272 | 0.790 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 2020 | 33 | 0.730 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2024 | 552 | 0.640 |
Why?
|
| Parkinsonian Disorders | 1 | 2021 | 285 | 0.600 |
Why?
|
| Pesticides | 1 | 2020 | 282 | 0.600 |
Why?
|
| Interleukin-4 | 1 | 2020 | 1114 | 0.540 |
Why?
|
| Antigens, CD | 1 | 2020 | 3911 | 0.340 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 2211 | 0.340 |
Why?
|
| Membrane Glycoproteins | 1 | 2020 | 3676 | 0.330 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 6820 | 0.220 |
Why?
|
| Optic Atrophy, Hereditary, Leber | 1 | 2022 | 50 | 0.200 |
Why?
|
| Silicon Dioxide | 1 | 2022 | 214 | 0.190 |
Why?
|
| Hospitals, Public | 1 | 2021 | 199 | 0.170 |
Why?
|
| Back Pain | 1 | 2023 | 541 | 0.170 |
Why?
|
| Th1 Cells | 1 | 2024 | 1000 | 0.170 |
Why?
|
| Hospitals, Urban | 1 | 2021 | 497 | 0.160 |
Why?
|
| Th17 Cells | 1 | 2024 | 780 | 0.150 |
Why?
|
| Planarians | 1 | 2017 | 55 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 36071 | 0.140 |
Why?
|
| Hospitals, Teaching | 1 | 2021 | 1168 | 0.130 |
Why?
|
| Lactic Acid | 1 | 2020 | 1129 | 0.120 |
Why?
|
| Phagocytosis | 1 | 2020 | 1530 | 0.120 |
Why?
|
| Patient Transfer | 1 | 2021 | 776 | 0.120 |
Why?
|
| Adenosine Triphosphate | 1 | 2020 | 1989 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 21796 | 0.100 |
Why?
|
| beta Catenin | 1 | 2017 | 1043 | 0.100 |
Why?
|
| B-Lymphocytes | 1 | 2024 | 4707 | 0.090 |
Why?
|
| Immunoglobulin G | 1 | 2021 | 4524 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2022 | 18939 | 0.080 |
Why?
|
| Mice, Knockout | 1 | 2021 | 14330 | 0.060 |
Why?
|
| Mice | 3 | 2022 | 80753 | 0.060 |
Why?
|
| Animals | 4 | 2022 | 167168 | 0.050 |
Why?
|
| Electron Transport Complex I | 1 | 2022 | 152 | 0.050 |
Why?
|
| Male | 4 | 2023 | 356684 | 0.040 |
Why?
|
| Hospital Bed Capacity | 1 | 2021 | 207 | 0.040 |
Why?
|
| RNA, Transfer | 1 | 2022 | 289 | 0.040 |
Why?
|
| Female | 4 | 2024 | 388048 | 0.040 |
Why?
|
| Spain | 1 | 2021 | 485 | 0.040 |
Why?
|
| Quarantine | 1 | 2021 | 174 | 0.040 |
Why?
|
| Photoreceptor Cells, Invertebrate | 1 | 2017 | 38 | 0.040 |
Why?
|
| gamma Catenin | 1 | 2017 | 44 | 0.040 |
Why?
|
| Armadillo Domain Proteins | 1 | 2017 | 24 | 0.040 |
Why?
|
| Brain | 1 | 2024 | 26743 | 0.040 |
Why?
|
| TCF Transcription Factors | 1 | 2017 | 138 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2022 | 848 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2017 | 452 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 2217 | 0.030 |
Why?
|
| Astrocytes | 1 | 2022 | 1328 | 0.030 |
Why?
|
| Humans | 4 | 2024 | 755800 | 0.030 |
Why?
|
| Adult | 1 | 2024 | 218056 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2017 | 1883 | 0.020 |
Why?
|
| Regeneration | 1 | 2017 | 1504 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2022 | 12756 | 0.020 |
Why?
|
| Homeostasis | 1 | 2017 | 3287 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2017 | 5089 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15753 | 0.010 |
Why?
|
| Models, Biological | 1 | 2017 | 9460 | 0.010 |
Why?
|
| Mutation | 1 | 2022 | 29817 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 167433 | 0.000 |
Why?
|
| Middle Aged | 1 | 2021 | 218133 | 0.000 |
Why?
|